Peptide record

TPDB23197

Antibacterial Antiviral Toxicity standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB23197
Antibacterial Antiviral Toxicity
Anti-infective peptides Toxicity and safety peptides
Peptipedia AI4AVP dbAMP 3.0 DRAVP 2.0
standard
No
A 13-aa standard-residue multi-activity (Antibacterial, Antiviral, and Toxicity) peptide sequence curated from Peptipedia, AI4AVP, dbAMP 3.0, and other sources, with an available 3D structural model.
Sequence
LWGEIWNTVKGLI
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C74H113N17O18
ARDCQHMFPSY
GILW
1528.81
6.94
1
1
7
-0
-0.67
0.508
142.31
Mammalian: 5.5 hour Yeast: 3 min E.coli: 2 min
11000
7.20
2
Residue Composition
number
0
A
0
R
1
N
0
D
0
C
1
E
0
Q
2
G
0
H
2
I
2
L
1
K
0
M
0
F
0
P
0
S
1
T
2
W
0
Y
1
V
Amino Acid Distribution
A: 0 R: 0 N: 1 D: 0 C: 0 E: 1 Q: 0 G: 2 H: 0 I: 2 L: 2 K: 1 M: 0 F: 0 P: 0 S: 0 T: 1 W: 2 Y: 0 V: 1
Chemical Descriptors
13 reviewed residue count
C74H113N17O18 sequence-only estimate (linear, free termini)
1528.81 sequence-only estimate (linear, free termini)
6.94 sequence-only estimate (linear, free termini)
-0 sequence-only estimate (linear, free termini)
-0.67 sequence-only estimate (linear, free termini)
0.508 sequence-only estimate (linear, free termini)
Evidence Records 3 records
Evidence 1 Activity

Activity

50% Cytotoxicity
Toxicity
68.50 µg/mL
Cytotoxic
50% Cytotoxicity | 68.50 | µg/mL | target cell: Vero cells

Target

Vero cells

Source & Reference

NA
DBAASP
Histidine-rich Modification of a Scorpion-derived Peptide Improves Bioavailability and Inhibitory Activity against HSV-1. | Theranostics | 2018
Evidence 2 Activity

Activity

Toxicity
Hemolytic Cytotoxic
Hemolytic_activity: [Ref.29290802]the cell viability of erythrocytes was also more than 95% at concentrations of Eval418 of 10 µg/mL or less. | Cytotoxicity: [Ref.29290802]Vero cell:CC50=68.50µg/mL the cell viability of the peptide-treated Vero cells was greater than 95% after treatment with Eval418 at 10 µg/mL.

Target

erythrocytes

Source & Reference

NA
DRAMP
Theranostics. 2018 Jan 1 8(1):199-211.
Evidence 3 Activity

Activity

Toxicity
Hemolytic Cytotoxic
Hemolytic_activity: [Ref.29290802]The hemolysis rate of human erythrocytes was less than 50% when the concentration of Eval418 was as high as 200 µg/mL. | Cytotoxicity: [Ref.29290802]Vero cells: CC50 = 68.50 µg/mL.

Target

erythrocytes

Source & Reference

NA
DRAMP
Theranostics. 2018 Jan 1 8(1):199-211.